MMCM
AMGN icon

Murphy & Mullick Capital Management’s Amgen AMGN Stock Holding History

Murphy & Mullick Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41K Hold
4
– – ﹤0.01% 621
2025
Q4 		$1.31K Hold
4
– – ﹤0.01% 635
2025
Q3 		$1.13K Hold
4
– – ﹤0.01% 628
2025
Q2 		$1.18K Hold
4
– – ﹤0.01% 617
2025
Q1 		$1.25K Hold
4
– – ﹤0.01% 602
2024
Q4 		$1.04K Buy
+4
New +$1.19K ﹤0.01% 601

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Murphy & Mullick Capital Management's AMGN Position: Q1 2026 in Review

Murphy & Mullick Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 4 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #621.

Murphy & Mullick Capital Management first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Murphy & Mullick Capital Management held 4 shares of Amgen worth $1.41K as of Q1 2026.
  • Murphy & Mullick Capital Management left its Amgen share count unchanged in Q1 2026.
  • Amgen made up ﹤0.01% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #621 holding.
  • Murphy & Mullick Capital Management first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.